Research conducted by Pioneer Group sheds light on the current investment trends shaping the life sciences landscape, offering insights into where capital is being allocated and what it means for the sector.
The fall in venture capital investment levels over recent years has caused some concern in the real estate sector.
Blog written by Elisabeth Goodman of RiverRhee Consulting...
Deepfake technology, which uses Artificial Intelligence (AI) to create highly realistic but fake images, audio, and videos, is rapidly emerging as a significant threat in the cyber security landscape. As cyber criminals adopt this technology to exploit vulnerabilities, businesses must understand its implications and strengthen their defences.
At this year’s ON Helix event ‘New Horizons for BIO Innovation’, a key note session expertly moderated by Precision Life’s Rowan Gardner, covered the ins and outs, or ones and zeros, of Tech-Bio. But first, have you protected all your valuable digital data from exfiltration? Is your cybersecurity up to snuff? A hostile attack leading to extortion and worse, can be just one click anyway, as data security expert Naveen Kaushik from ZenZero demonstrated. In May, United Health confirmed the company paid hackers a $22m ransom, which led to questioning of the CEO by US Senators.
Tony Jones, CEO and Richard Dickinson, Chief Technical Specialist, One Nucleus
Guest blog by Aon...
Too many investments in life science companies are made without the appropriate human capital due diligence which can lead to problems post-deal in areas like poor talent retention and excessive salary costs. Aon’s Keaton Hoffman – Partner, Executive Compensation, Talent Solutions and Matthew Robinson – Life Science Industry Leader, explore why getting the human capital due diligence right is vital and where venture capital firms and the wider private equity market should be focusing.
Jasmin Bannister, Business Development Manager
The life sciences industry plays a significant role in improving patient lives, but its operations can have a significant environmental impact. Energy consumption in labs is a major contributor and reducing this consumption is crucial for a more sustainable future.
Guest Blog Post by Cushman & Wakefield’s Kiran Patel (Associate, Head of National Office & Life Sciences Research) and Nick Blevins (Partner, Occupier Representation, Life Sciences).
Guest blog post by Molly Andrews, UK Dementia Research Institute; Priya Kalia, SciTribe; Miranda Weston-Smith, BioBeat
“There is an urgent need for innovative solutions and investment in the accurate diagnosis of neurodegenerative disease, and the development of effective treatment options.”
Professor Zoe Kourtzi, Professor of Computational Cognitive Neuroscience, University of Cambridge
